In an attempt to generate a suitable animal model to study the infectivity and possible pathogenicity of human immunodeficiency viruses, we intravenously inoculated juvenile rhesus macaques and African green monkeys with a molecularly cloned virus, human immunodeficiency virus type 2 HIV-2sb/iSy, as well as with the uncloned HIV-2,ih Z virus. Infection was monitored by virus recovery from the peripheral blood cells and by seroconversion against HIV-2 antigens measured by Western immunoblot, radioimmunoprecipitation, and enzyme-linked immunosorbent assay. We successfully infected two out of two macaques with the molecularly cloned virus and one macaque out of two with the HIV-2nih-z. No evidence of infection was seen in the African green monkeys with either virus. We followed the infected animals for 2 years. The animals remained healthy, although we observed intermittent lymphadenopathy and a transient decrease in the absolute number of circulating CD4+ T lymphocytes in both animals infected with the molecularly cloned virus. Virus isolation from the peripheral blood cells of the infected animals was successful only within the first few months after inoculation. Evidence of persistent infection was provided by the detection of proviral DNA by polymerase chain reaction analysis of the blood cells of the inoculated animals and by the stability of antiviral antibody titers. To evaluate the genetic drift of the proviral DNA, we molecularly cloned viruses which were reisolated 1 and 5 months postinoculation from one of these animals. Comparison of the DNA sequences of the envelope genes of both these isolates indicated that a low degree of variation (0.2%) in the envelope protein had occurred in vivo during the 5-month period. These data suggest that the use of HIV-2sb,/iSy in rhesus macaques may represent a good animal model system to study prevention of viral infection. In particular, molecularly cloned virus can be manipulated for functional studies of viral genes in the pathogenesis of acquired immune deficiency syndrome and provides a reproducible source of virus for vaccine studies.
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The acquired immunodeficiency syndrome is a progressive life-threatening illness caused by human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) (2, 4, 12, 25) . HIV-1 infects in vitro and in vivo CD4+ T cells and monocytes or macrophages (13, 17, 26) , which are pivotal cells for the function of the immune system.
To study the pathogenesis of acquired immunodeficiency syndrome and the prophylaxis of HIV-1 infection, suitable animal models are needed. In addition to humans, HIV-1 infects only higher primates, i.e., chimpanzees (1, 8, 11, 22) and gibbons (P. D. Markham, W. Jarrett, E. Gard, M. G. Sarngadharan, and R. C. Gallo, Abstr. 3rd Int. Conf. on AIDS, 1987, p. 65), which, as protected species, are scarce. Moreover, of these primates inoculated to date, none show signs of disease. HIV-2, isolated from West African acquired immunodeficiency syndrome patients (4, 32) , is genetically and immunologically related to both HIV-1 (6, 14, 32) and the various simian immunodeficiency viruses (SIV) (3, 7, 9, 14, 16) . HIV-2 has been associated with acquired immunodeficiency syndrome cases (4), although there is a far lower morbidity rate and far less spread of this virus compared with HIV-1 (19 (30) . The filter was hybridized by using three internal BamHI fragments of the molecular clone HIV-2sbl/isy, The nucleotide sequence of the proviral DNA was obtained by the dideoxy-chain termination procedure (29) .
Phenotypical analysis of monkey T cells. The expression of surface membrane CD4 and CD8 antigens was assessed by direct immunofluorescence assay on live cells by using phycoerythrin-conjugated Leu3a (anti-CD4) and fluoresceinisothiocyanate-conjugated Leu2a (anti-CD8) monoclonal antibodies. Briefly, 1 x 106 mononuclear cells were repeatedly washed with cold phosphate-buffered saline and simultaneously incubated with the two monoclonal antibodies for 30 min at room temperature. The cells were then washed three times, and the positivity was scored under a Leitz fluorescence microscope by two investigators. More than 200 cells were analyzed for each sample.
Neutralization assay. Sera from infected animals were tested for the presence of neutralizing antibodies (28) to both HIV-2sbl/isy and HIV-2nih-z by using CEM-SS cells (21) as targets for infectivity by cell-free virus. The various sera (diluted 1:10 to 1:270) were incubated with the virus for 1 h at 4°C prior to infection of target cells. Virus expression was monitored by an indirect immunofluorescence assay for HIV-2 p24 by using a specific monoclonal antibody (F. Veronese, unpublished data).
RESULTS
In the first experiment ( 
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; , > -4F proteins in autoradiograms progressively increased with time after virus inoculation. A human serum used as a positive control also immunoprecipitated the major gag protein (p24) from the same labeled infected cell lysate, while only serum from animal 176 precipitated p24, weakly.
Detection of serum-neutralizing antibodies. Only serum of animal 172, which was inoculated with HIV-2nih-z, showed significant neutralizing antibodies against the homologous virus (results are summarized in Table 2 ). The neutralizing ability of serum from animal 172 is type specific, since the same serum failed to neutralize HIV-2Sbi/isy. The sera of both the animals inoculated with the HIV-2sbl/isy failed to neutralize the homologous virus as well as HIV-2nih-z.
Virus recovery and immunological status of the infected animals. Virus isolation from the peripheral blood of the inoculated animals was performed monthly. Uninfected rhesus macaque peripheral blood mononuclear cells (PBMCs) or human neoplastic T-cell lines were used as targets for virus isolation. Virus was recovered easily during the first 5 months after infection of animal 177 and only during the first 3 months for animals 172 and 176. To verify that the virus recovered from the infected animal was the virus inoculated, we performed Southern blot analysis on DNA extracted from the cultured infected cells. BamHI digests of the proviral DNAs of the original virus HIV-2sbl/isy as well as of the 1-and 5-month isolates from animal 177 showed an indistinguishable pattern of hybridization when the three internal BamHI fragments from the HIV-2sbi/isy clone were used as a probe (Fig. 3) .
Immunohematological analysis of the peripheral blood cells of the infected animals was performed every few months the first year after infection and every month thereafter. We monitored the absolute number of CD4+ T cells in the peripheral blood, since it is one of the most reliable tests predictive of disease development in humans. Approximately 9 months after infection, we detected a decrease in CD4+ T cells in the blood of animals 176 and 177 (Fig. 4) 
DISCUSSION
The availability of an HIV-2 molecular clone which infects rhesus macaques in vivo enabled us to start to address some questions on the pathophysiology of HIV infection with a human virus. Our results indicate that minimal genetic drift of the viral genome occurred in vivo in the infected macaques over the course of a 5-month observation period. Furthermore, our data suggest that the high degree of viral genetic variability first described by Hahn et al. (15) and more recently reexamined by the polymerase chain reaction technique (20) by using several isolates obtained by cell culture from the same individuals infected with HIV-1 might be due to selection of viral genotypes already present in the infected individuals rather than to fast nucleotide changes in the viral RNA. This concept is supported by the demonstration that each viral strain contains multiple genotypes (18) . If so, it implies that HIV-2, and inferentially also HIV-1, existed as a myriad of variants at the earliest time of the epidemic. An alternative explanation for the low genetic drift detected in the HIV-2Sbl/isy passages in rhesus macaques could be that the virus is not subjected to immune-selective pressure resulting in propagation of antigenic variants, since our animals infected with the molecularly cloned virus did not develop neutralizing antibodies. However, this conclusion does not take into account the role of cell-mediated immunity, which could also eliminate virus-infected cells, since we did not measure it in these infected animals. The failure to isolate virus from the PBMCs of HIV-2-inoculated rhesus macaques 3 to 5 months postinoculation seems to suggest a low rate of virus replication in PBMCs, which, in turn, could also explain the low degree of genetic variation observed. However, despite the failure to isolate virus from the PBMCs of the infected animals, viral sequences could be detected in the PBMC DNA of the infected animals by polymerase chain reaction and the antibody titer in the animals remained constant, suggesting that a certain level of viral replication must occur in PBMCs and in other lymphoid organs in the infected animals. The transient decrease of CD4+ T cells in the peripheral blood of the two animals infected with HIV-2sbl/isy indicates that some pathogenetic effect is generated even with the apparently low level of viral replication.
Rhesus macaques can be infected with HIV-2sbl/isy as well as with other HIV-2 strains (5, 10, 23, 27) , and this animal model can be exploited to study prevention of infection by using specific subunit vaccines obtained by the expression of relevant protein of the HIV-2sbl/isy molecular clone by recombinant DNA technology. Moreover, the availability of a proviral molecular clone infection in vivo provides a suitable tool for genetic manipulation to study the effect of accessory genes such as vpx, vpr, nef, and vif in viral infectivity and possibly pathogenicity in vivo.
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